Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
QuintilesIMS
Colorcon
Merck
Baxter
Cipla
US Department of Justice
Federal Trade Commission
Farmers Insurance
Citi

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020250

« Back to Dashboard

NDA 020250 describes HALFAN, which is a drug marketed by Glaxosmithkline and is included in one NDA. Additional details are available on the HALFAN profile page.

The generic ingredient in HALFAN is halofantrine hydrochloride. Additional details are available on the halofantrine hydrochloride profile page.
Summary for 020250
Tradename:HALFAN
Applicant:Glaxosmithkline
Ingredient:halofantrine hydrochloride
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength250MG
Approval Date:Jul 24, 1992TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Express Scripts
US Army
McKinsey
US Department of Justice
Argus Health
Federal Trade Commission
Chubb
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot